Atara Biotherapeutics director Brian Cherry acquires 104,166 common shares for $999,993.60
ATRA•Director buys additional Atara Biotherapeutics shares
- Atara Biotherapeutics director Brian N. Cherry bought 104,166 common shares in a $9.6 per-share purchase.
- His direct stake increased to 166,486 shares following the transaction.
